rediff.com
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Sales 458.15 568.65 617.20 755.43 564.79
Operating profit 184.05 267.24 261.38 343.60 236.39
Interest 3.07 1.65 1.72 2.93 3.30
Gross profit 212.36 289.85 280.95 484.34 277.21
EPS (Rs) 5.55 7.82 7.58 14.20 7.72
Half yearly  results in details
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Other income 31.38 24.26 21.29 143.67 44.12
Stock adjustment 28.81 30.47 -15.31 -18.98 -41.37
Raw material 73.90 124.57 196.63 248.76 210.70
Power and fuel - - - - -
Employee expenses 87.42 52.78 50.68 56.13 44.35
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - 4.31 4.33 -
Expenses capitalised - - - - -
Other expenses 83.97 93.58 119.51 121.59 114.72
Provisions made - - - - -
Depreciation 24.29 21.63 21.30 20.93 18.17
Taxation 46.67 69.20 66.67 101.95 62.40
Net profit / loss 141.40 199.02 192.97 361.46 196.64
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 25.46 25.46 25.46 25.46 25.46
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 40.17 47.00 42.35 45.48 41.85
GPM (%) 43.38 48.89 44.00 53.87 45.53
NPM (%) 28.88 33.57 30.22 40.20 32.29
Close
Add Suven Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close